Jinbo Zhao
Dalian, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Options after progression on first-line CDK4/6 inhibitors in advanced breast cancer patients.
Journal: Therapeutic advances in medical oncology
Published: November 19, 2024
Next-generation sequencing-based detection in a breast MMPMN patient with EGFR T790M mutation: a rare case report and literature review.
Journal: Frontiers in oncology
Published: April 11, 2023
Pseudoprogression after advanced first-line endocrine therapy in metastatic breast cancer with bone metastasis: A case report.
Journal: Frontiers in oncology
Published: November 15, 2022
Favorable Response to Olaparib in a Patient with Cancer of Unknown Primary Carrying a Germline BRCA1 R71K Mutation.
Journal: OncoTargets and therapy
Published: August 18, 2021
Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
Journal: Molecular carcinogenesis
Published: February 01, 2020
High Expression of CCR7 Predicts Lymph Node Metastasis and Good Prognosis in Triple Negative Breast Cancer.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: April 03, 2017
The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer.
Journal: OncoTargets and therapy
Published: March 31, 2017
EphB4 regulates the growth and migration of pancreatic cancer cells.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: February 11, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026